COMPANY PROFILE

Genelabs Technologies

Explore full profile

Drug Discovery | News and information in drug research

Redwood City, United StatesFounded 1983Health

Valuation $50–100M Last recorded · 2008

Headcount <100 Current team size

Total funding $10–50M Disclosed equity funding

Unlock exact values

About Genelabs Technologies

Genelabs operates in the biotechnology and pharmacology sectors, focusing on the discovery of new candidate medications. The company employs advanced computational methods to screen and identify small molecules that bind to specific drug targets, aiming to develop effective therapeutic solutions. Genelabs serves pharmaceutical companies and research institutions, providing them with cutting-edge drug discovery services. The business model revolves around offering specialized screening assays and virtual screening services, which help clients identify potential drug compounds with desirable properties such as oral bioavailability, chemical stability, and minimal toxicity. Revenue is generated through service contracts and collaborative research agreements.

MoreLess Source: Dealroom company data

At a glance

Status: Acquired
Founded: 1983
Headquarters: Redwood City, United States
Employees: 25
Open positions: None listed
Dealroom signal: 75.8/100
Industry: Health
Sector: Health, Biotechnology
Client focus: b2c
Links: Website LinkedIn

Knowledge graph

Founder mafia, market maps, research and news connected to this company by Dealroom

Funding history

3 recorded events

Company financing events and reported valuations.

Deal type	Date	Amount	Valuation	Investors	Source
ACQUISITION✓Exit	Oct 2008	$57M	$57M	GSK	—
EARLY VC✓Equity / VC	Jun 2007	$9M	$36M	Undisclosed	—

Showing the latest 2 of 3 recorded eventsBook a demo for the full funding history →

Growth signals

Genelabs Technologies website traffic

Latest recorded traffic for Genelabs Technologies is 0 monthly website visits, down 100% over the last three months. Genelabs Technologies's team grew 8.7% over the past year.

Latest monthly visits0 3-month web change-100% 1-year team growth+8.7%

Monthly website visitsApr 2016–Oct 2020

Explore monthly traffic historyTrack growth over time and compare with peersBook a demo

Summary metrics are public; monthly history is available with a demoCompare with peers →

Similar companies

Closest operating peers by Dealroom taxonomy

Company identity and context are open; selected comparison metrics preview what is available on the platform.

Company	Headquarters	Status	Employees	Total funding	Valuation
BRBrain Tumour ResearchDriving research and funding to find a cure for brain tumours, supporting patients and families with comprehensive resources	London, United Kingdom	Operational	—	—	—
TBTLDR BiotechThis daily newsletter covers all the major biotech and pharma updates that you need to know, all in one daily email	Vancouver, Canada	Operational
IMIdeas MatterA free, 8-week, digital fellowship for aspiring biology writers who want to reach a wide audience	—	Operational
HAhattrbridge.comLearn about a rare, inherited condition called hATTR amyloidosis by exploring information about the symptoms, cause, and path to diagnosis	—	Operational
FLFill It LocalConnecting customers with local pharmacies for accessible, discounted prescriptions	Alpharetta, United States	Operational
RORoute66postThe Ten Lies Of Covid-19 Debunked With Science & Data	—	Operational
BIBiomifyThe HUGE Health Benefits of Autophagy	—	Operational
REREADYREADY offers innovative solutions for women’s sexual health and hygiene	Warsaw, Poland	Operational